TNF-α/IL-1β-Licensed hADSCs Alleviate Cholestatic Liver Injury and Fibrosis in Mice via COX-2/PGE2 Pathway

Researchers suggested that TNF-α/IL-1β pretreatment enhances the efficacy of adipose tissue-derived stem cells in mice with cholestatic liver injury, partially through the COX-2/PGE2 pathway.